Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Chesapeake, VA
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Manassas, VA
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Manassas, VA
Click here to add this to my saved trials
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Spokane, WA
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Seattle, WA
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Spokane, WA
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Tacoma, WA
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated:  3/11/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period
Status: Enrolling
Updated: 3/11/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Status: Enrolling
Updated:  3/12/2013
WakeMed
mi
from
Raleigh, NC
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Status: Enrolling
Updated: 3/12/2013
WakeMed
mi
from
Raleigh, NC
Click here to add this to my saved trials
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Status: Enrolling
Updated:  3/12/2013
UNC-Rex Health Care
mi
from
Raleigh, NC
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Status: Enrolling
Updated: 3/12/2013
UNC-Rex Health Care
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Los Angeles, CA
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Miami, FL
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Topeka, KA
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Hazard, KY
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Hazard, KY
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Alexandria, LA
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Lansing, MI
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Las Vegas, NV
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Cincinnati, OH
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Chattanooga, TN
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated:  3/15/2013
Clinical Research Facility
mi
from
Fort Worth, TX
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)
Status: Enrolling
Updated: 3/15/2013
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Southern Arizona Limb Salvage Alliance
mi
from
Tucson, AZ
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Southern Arizona Limb Salvage Alliance
mi
from
Tucson, AZ
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Center for Clinical Research, Inc
mi
from
Richmond, CA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Center for Clinical Research, Inc
mi
from
Richmond, CA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Innovative Medical Technologies
mi
from
Los Angeles, CA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Innovative Medical Technologies
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Diabetic Foot and Wound Center
mi
from
Denver, CO
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Diabetic Foot and Wound Center
mi
from
Denver, CO
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Hines VA Hospital
mi
from
Hines, IL
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Hines VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Cleveland Clinic Foundation
mi
from
Cleveland, OH
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Blair Medical Associates Inc.
mi
from
Altoona, PA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Blair Medical Associates Inc.
mi
from
Altoona, PA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Temple University- School of Podiatric Medicine
mi
from
Philadelphia, PA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Temple University- School of Podiatric Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Complete Family Footcare
mi
from
McAllen, TX
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Complete Family Footcare
mi
from
McAllen, TX
Click here to add this to my saved trials
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Status: Enrolling
Updated:  3/20/2013
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins
Status: Enrolling
Updated: 3/20/2013
Zablocki VA Medical Center, Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Birmingham, AL
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Fort Smith, AR
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Santa Clara, CA
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Aurora, CO
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Decatur, GA
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Park Ridge, IL
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Indianapolis, IN
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Louisville, KY
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Metairie, LA
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Baltimore, MD
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Helena, MT
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Helena, MT
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Henderson, NV
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Newark, NJ
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
New York, NY
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Ashville, NC
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Cleveland, OH
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Tulsa, OK
12-Week, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Metformin DR in Subjects With Type 2 Diabetes Mellitus
12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials